Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting histone methyltransferase EZH2 as cancer treatment.

Targeting histone methyltransferase EZH2 as cancer treatment. J Biochem. 2014 Nov; 156(5):249-57.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.